Delivery Order SPE2DB22D9207-SPE2DB24FH5ET
Award Date
8/27/24
Potential Completion Date
9/18/24
Potential Value
$15K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB program. The single-award indefinite delivery contract (IDC) has a ceiling value of up to $499,999,999 and runs through December 31, 2025. Under this contract, DMS Pharmaceutical Group provides a comprehensive range of pharmaceutical items, including both common medications and specialized drugs, to support the diverse medical supply...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was issued by the Defense Logistics Agency (DLA) as a Firm Fixed Price delivery order under the SPE2DB program. The contract, valued at $1,547.40, is for the delivery of Xolair 150 mg/ml syringes to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a...
This contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB Indefinite Delivery Contract (IDC) valued at $499,999,999. The contract covers a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide. The current...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract valued at up to $499,999,999. The contract is for the delivery of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical supplies, to support the recurring medical needs of military healthcare facilities worldwide. The specific product...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was issued by the Defense Logistics Agency (DLA) under the SPE2DB program. The $4,642.20 firm fixed-price delivery order is for the provision of Xolair 150 mg/mL syringes, a specialized pharmaceutical product, with a period of performance through January 25, 2024. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA to supply a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $3,094.80 firm fixed-price delivery order contract is for the supply of Xolair 150 mg/mL syringes to support the recurring medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was issued by the Defense Logistics Agency (DLA) under the SPE2DB program. The $74,275.20 firm fixed-price delivery order covers the supply of Xolair 150 mg/1.2 ml powder vials to support the recurring medical needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which allows the agency to issue...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB program. The $18,612.48 firm fixed-price contract is for the delivery of the pharmaceutical product Xolair 150 mg/mL syringe to support the medical supply needs of Department of Defense (DoD) healthcare facilities. The contract has no set-aside designation and is part of DMS Pharmaceutical Group's broader indefinite delivery contract...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was issued by the Defense Logistics Agency (DLA) as a delivery order under the SPE2DB Indefinite Delivery Contract (IDC) valued at $499,999,999 and valid through November 2026. The contract provides the DLA with a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) valued at $499,999,999 and valid through November 2026. The delivery order, valued at $89,953.38, is for the provision of a range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical...